中国で最高のMRI検査医師 - トップ6名の医師

Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.

She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.

She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.

Dr. Yao Yi leads the Epilepsy Center at Xiamen Humanity Hospital. He is an expert in functional neurology and neurosurgery for children and adults. Dr. Yi specializes in treating complex drug-resistant epilepsy and brain tumors. He holds a Standing Council position at the China Association Against Epilepsy.

• Serves as Vice Chairman of the Epilepsy Surgery Foundation.
• Expert in brain functional mapping and microsurgery for vascular conditions.
• Performs deep brain stimulation (DBS) and advanced neurosurgical planning.
• Works at a tertiary center equipped with intraoperative MRI and robotic systems.

Dr. LV Xiao Jun is a national expert in psycho-oncology. He serves as the Executive Director of Medical Oncology at Xiamen Humanity Hospital. Dr. LV focuses on lung, breast, and gastrointestinal cancer care. He integrates psychological distress screening into tumor therapy.

• Sits on the Standing Committee for the Chinese Anti-Cancer Association’s psycho-oncology branch.
• Expert in lung cancer management for the Fujian Anti-Cancer Association.
• Practices at a tertiary hospital treating 1,000,000 patients every year.
• Treats solid tumors using comprehensive methods and palliative care techniques.

Dr. Zheng Wei Hong is the Director of Neurology and a discipline leader at Xiamen Humanity Hospital. He is a professor and master's supervisor at Xiamen University. Dr. Zheng focuses on cerebral infarction, epilepsy, and Parkinson's disease treatment. He also manages complex neuroimmunological and neuromuscular disorders like myasthenia gravis.

• Served as Director of Neurology at Xiamen University Affiliated Zhongshan Hospital.
• Committee member of the Chinese Medical Association’s Neuroimmunology Group.
• Sits on the Standing Committee for Stroke Screening and Prevention for the Ministry of Health.
• Standing Director of the Fujian Anti-Epilepsy Association.

Dr. Yan Zhi Ping serves as Director of Radiology at Xiamen Humanity Hospital. He specializes in the early diagnosis of lung cancer and brain tumors. Dr. Yan has published over 30 academic papers and edited several professional monographs. He received the Fujian Provincial Third Prize for Science and Technology Progress.

• Identifies diseases of the central nervous system, musculoskeletal system, and abdomen.
• Expert in CT, MRI, and cerebral functional imaging.
• Vice Chairman of both the Xiamen Radiological Society and the Xiamen Medical Doctor Association.
• Practices at a tertiary hospital featuring mainland China's first BNCT center.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.